You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 152 No. 7, July 1, 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

CD4 lymphocyte count as an indicator of delay in seeking human immunodeficiency virus-related treatment

M. H. Katz, A. B. Bindman, D. Keane and A. K. Chan
Department of Public Health, University of California, San Francisco.

BACKGROUND--As many as half of patients infected with the human immunodeficiency virus who are medically eligible for Pneumocystis prophylaxis and zidovudine treatment have not received these treatments. We used the CD4 lymphocyte count as an indicator of delay in seeking treatment among patients infected with human immunodeficiency virus and assessed whether insurance status was associated with the stage of illness when care is initiated. METHODS--Data from 96 patients who initiated medical care at a university acquired immunodeficiency syndrome clinic from August 1989 to January 1991 were retrospectively reviewed. RESULTS--Patients initiated care at a relatively late stage of illness (mean CD4 lymphocyte count, 0.37 x 10(9)/L [369/mm3]), and 29% were below the threshold for Pneumocystis prophylaxis. Patients with private insurance had significantly lower CD4 counts (mean, 0.27 x 10(9)/L) than did individuals with public insurance (mean, 0.46 x 10(9)/L). CD4 counts did not increase during the 18-month study period. CONCLUSIONS--The majority of patients infected with human immunodeficiency virus are eligible for medical therapy and could benefit by initiating care sooner. Private insurance was not associated with initiating early care, supporting anecdotal reports that some privately insured individuals may be reluctant to seek care for a human immunodeficiency virus-related condition.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force
Chou et al.
ANN INTERN MED 2005;143:55-73.
ABSTRACT | FULL TEXT  

Identifying Undiagnosed Human Immunodeficiency Virus: The Yield of Routine, Voluntary Inpatient Testing
Walensky et al.
Arch Intern Med 2002;162:887-892.
ABSTRACT | FULL TEXT  

Think HIV: Why Physicians Should Lower Their Threshold for HIV Testing
Freedberg and Samet
Arch Intern Med 1999;159:1994-2000.
FULL TEXT  

Monitoring the Consequences of Uninsurance: A Review of Methodologies
Brown et al.
Med Care Res Rev 1998;55:177-210.
ABSTRACT  

Trillion Virion Delay: Time From Testing Positive for HIV to Presentation for Primary Care
Samet et al.
Arch Intern Med 1998;158:734-740.
ABSTRACT | FULL TEXT  

Factors Associated With HIV Testing Among Sexually Active Adolescents: A Massachusetts Survey
Samet et al.
Pediatrics 1997;100:371-377.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.